Presented at HFSA, this analysis shows non-invasive sensing can detect early volume overload in Stage A patients before symptoms develop. The findings support prevention-focused care models that identify physiologic risk sooner. For value-based care leaders, the evidence reinforces opportunities to intervene earlier and reduce downstream clinical deterioration and cost burden.